• Mon news: Novartis in $745M radiopharma pact. Novo launches Wegovy in China. COVID-era telehealth prescribing extended. Hims & Hers GLP-1 tracker. Promising Gilead liver disease trial. See more on our front page

Bacterin Biologics

Quote




Record Quarters my ass, This company is as stagnant as a cess pool and all because of The Crook & Mousy Molly. And now (hold onto your hats) There goes The main Taggart Brother. Yep, thats right...He's out and That folks is why this company will continue to dwindle back into the dark corners of Biologics that it emerged from. This company has no true IP, pays for it sales and continues to borrow boat loads of money from its investors only to pilfer through it like candy. Anybody that was worth anything at that company has since packed up and hitched a ride. Believe nothing you ever hear from the Crook's mouth. He is a liar and a cheat.
Molly, Shut up....
 








All the hatin' on this site. Jesus, just move on, quit living in the past.

Didn't this same site regularly blast Taggart anyway?

Pretty much EBITDA break-even last 2 quarters, and revenues up 109 % year over year.

Sales are screaming, hottest product on the market. Winning, duh.
 




Anonymous said:
All the hatin' on this site. Jesus, just move on, quit living in the past.

Didn't this same site regularly blast Taggart anyway?

Pretty much EBITDA break-even last 2 quarters, and revenues up 109 % year over year.

Sales are screaming, hottest product on the market. Winning, duh.
Click to expand...

Just another post from either Molly the mouth or Josh.

Soon you will be living in the past, With Taggart gone investors are selling their paper like crazy and bacterin will soon run out of places to borrow more money in order to keep the lie going. Record quarter? Just where did those sales come from? not through your direct sales force, sales down nationwide and in some states over 400%

You call it winning, more like winning at losing. Huge turn-overs 15 upper level management personnel fired or resigned in the last three months. pretty soon you guys will run out of people to promote from within and you Molly will be right back to bar-tending where you came from. Josh, with Taggart gone where ya get get those sales now, might have to start doing some real work or go back to modeling pretty boy...

You gonna strip down to your packers jersey at the NSM this year again. Your so vain, you probably think this post is about ya...


Still Stuck
 








Anonymous said:
All the hatin' on this site. Jesus, just move on, quit living in the past.

Didn't this same site regularly blast Taggart anyway?

Pretty much EBITDA break-even last 2 quarters, and revenues up 109 % year over year.

Sales are screaming, hottest product on the market. Winning, duh.
Click to expand...

Worst ad in the last 5 years......Winning, duh....I assume Montana is running 6 months behind the rest of the country. They act like they were the first company to toss cancellous bone in acid, uh, NO. No IP, no clue and clueless over all. The blonde, female sales and marketing group are lacking a basic education let alone industry intelligence. Must go over well in the wide open spaces of MT.
 




















Well, poor sucker, I think Crook may hire these guys for house boys or something, probably doing some yard work too on Crook's ranch. Just happy to have a job? They don't know any better, so feed them some of the kool aid, don't give them a commission statement, then once they wake up get rid of them. But sales are still up!! Look again at the end of Q4. Time is on the side of the people Crook has screwed. Poor AIMs sales guys, they will be sorry!!

My advice just choose a solid, high integrity company to work for. Remember, if it doesn't seem to add up it probly doesn't. 250,000 or anything close to 600,000 is just kool aid marketing paid for by thie big GUY.
 








love the fact that my company is up over 3$'s since I got my options in January and Bacterin stock continues to fall and is under 3$ in value--I love that kind of karma!!!!!
 








Anonymous said:
bacterin stock getting close to 2$ now--how low can it go
Click to expand...
OH, it can & will go a lot lower.......spending is more than income. & investors are finally getting a glimse of the incompentcy our
Exalted leader the Crook has been preaching for the last year....Glad i didnt drink the cool-aid bitches....its fun watching it burn......

Sincerely,
Still stuck.....but not for long.. .
 




Well, looks like my favorite company is at it again. Looks like they have called an emergency Regional Vice President meeting & all the players are in Bozeman....and some will be let go...Definatley some re-structruring going on...This will be a vain attempt to appease the share holders & any other future investors..... The ship is sinking slowly but sinking for sure..Stocks down under 2 bucks and continuing to drop..I can't think of a better thing to happen to a guy like Guy.....Cant wait to hear the earnings announcements (or lack of) of Thursday...Boy they sure do keep turning out those lawsuits though...Bacterin has been responsible for filling in excess of 30 lawsuits in the short while they have been in business & most have been thrown out as frivolous and almost all are handled by different legal firms each time...Makes ya wonder if they have been paying their legal fees as well.....

Still stuck but getting my marshmallows ready for the fire....
 




Ha ha ha ha ha ha ha ha--under a buck fifty and sinking. Totally awesome and hope they are all let go. Worst people I have ever worked with and hope they all sink--so happy to see the jerks go DOWN!!!!!!
 




Anonymous said:
The following table summarizes our current patent portfolio, including patents covering technology licensed by us for use or inclusion in certain of our products:
*
***
*
***
*
First
*
Serial or
*
Date Filed
*
***
Title
*
Business Purpose
*
Inventor
*
Patent Number
*
or Granted
*
Status
1. Pending U.S. Applications
*
*
*
*
*
*
*
MEDICAL DEVICE INCLUDING A BIOACTIVE IN A NON-IONIC AND AN IONIC FORM AND METHODS OF PREPARATION THEREOF
*
This application arose out of a now defunct project. We retained rights as the technology may prove useful in the future. The patent describes the modification of elution profiles via active agent equilibration; it is potentially applicable to many coated products.
*
Mike Johnson
*
11/864,360
*
9/28/2007
*
Undergoing further examination
ANTIMICROBIAL COATING FOR INHIBITION OF BACTERIAL ADHESION AND BIOFILM FORMATION* ®
*
This application relates to the coating used for the Elutia® wound drain and for the Bard BioBloc coating on their HemoStar hemodialysis catheter. The efficacy period can be varied according to the desired outcome; the coating has shown in vitro efficacy for between 7 and 21 days.
*
Guy Cook
*
10/891,885
*
7/15/2004
*
Non-final Office Action mailed 9/15/09; response submitted 12/15/09
PROCESS FOR DEMINERALIZATION OF BONE MATRIX WITH PRESERVATION OF NATURAL GROWTH FACTORS
*
This application is intended to protect OsteoSponge®, a core product produced by our Biologics division.* OsteoSponge® is a novel form of demineralized bone matrix which provides a natural scaffold for cellular growth and exposes bone growth inducing proteins to the healing environment.
*
Nancy J. Shelby
*
12/130,384
*
5/30/2008
*
First examination: November 2010 (estimated)
2. Pending Foreign Applications
*
*
*
*
*
*
MEDICAL DEVICE INCLUDING A* BIOACTIVE IN A NON-IONIC AND AN IONIC FORM AND METHODS OF PREPARATION THEREOF
*
This application arose out of a now defunct project. We retained rights as the technology may prove useful in the future. The patent describes the modification of elution profiles via active agent equilibration and is potentially applicable to many coated products.
*
Mike Johnson
*
PCT/US2007/ 079924
*
9/28/2007
*
Preliminary Report on Patentability generated 3/13/09
ANTIMICROBIAL COATING FOR INHIBITION OF BACTERIAL ADHESION AND BIOFILM FORMATION
*
This application relates to the coating used for the Elutia® wound drain and for the Bard BioBloc coating on their HemoStar hemodialysis catheter. The efficacy period can be varied according to the desired outcome; the coating has shown in vitro efficacy for between 7 and 21 days.
*
Guy Cook
*
PCT/US2005/ 015162
*
4/28/2005
*
Entered National Phase in: Europe, Australia, Canada, Japan
*
27
*
*
PROCESS FOR DEMINERALIZATION OF BONE MATRIX WITH PRESERVATION OF NATURAL GROWTH FACTORS
*
This application is intended to protect OsteoSponge®, a core product produced by our Biologics division.* OsteoSponge® is a novel form of demineralized bone matrix which provides a natural scaffold for cellular growth and exposes bone growth inducing proteins to the healing environment.
*
Nancy J. Shelby
*
PCT/US2008/ 006942
*
6/2/2008
*
Entered national Phase in: Europe, Canada, Mexico, Korea
AN ELASTOMERIC ARTICLE INCORPORATED WITH A BROAD SPECTRUM ANTIMICROBIAL
*
This application was generated as a means of protecting the technology used for a forthcoming product. We have observed long term (over 30 days) in vitro efficacy with this technology.
*
Benjamin P. Luchsinger
*
PCT/US2009/ 005103
*
9/11/2009
*
Awaiting International Search Report (this application will enter the US through PCT)
3. In-Licensed Intellectual Property
*
*
*
*
*
*
*
SWOLLEN DEMINERALIZED BONE PARTICLES, FLOWABLE OSTEOGENIC COMPOSITION CONTAINING SAME AND USE OF THE COMPOSITION IN THE REPAIR OF OSSEOUS DEFECTS
*
This patent protects OsteoSelect®, Bacterin’s DBM putty. OsteoSelect® has exceptional handling characteristics and can easily be molded into any shape and compressed into bony voids. Bacterin employs a low-dose, low-temperature sterilization process to provide maximum osteoinductive potential while maintaining device-level sterility.
*
Simon Bogdansky
*
5,284,655
*
2/8/1994
*
Granted - US Expires April 2011
FLOWABLE DEMINERALIZED BONE POWDER COMPOSITION AND ITS USE IN BONE REPAIR
*
This patent protects OsteoSelect®, Bacterin’s DBM putty. OsteoSelect® has exceptional handling characteristics and can easily be molded into any* shape and compressed into bony voids. Bacterin employs a low-dose, low-temperature sterilization process to provide maximum osteoinductive potential while maintaining device-level sterility.
*
Robert K. O’Leary
*
5,290,558
*
3/1/1994
*
Granted - US Expires April 2011
*
28
*
*
We believe our patent filings and patent position will facilitate growth and enhance our proprietary core competencies, enabling us to protect and expand revenue growth and stockholder value in the future.* We expect that additional patent applications will be filed and prosecuted as inventions are discovered, technological improvements and processes are developed and specific applications are identified. The status of individual patents and patent jurisdiction is maintained in our internal records.* We anticipate, however, that there may be instances in which we enter into collaborative research and development agreements with medical device companies under such terms that the medical device company may or will retain a right to make future patent filings arising from such cooperative development agreement. In such instances, we will attempt to protect our overall patent use rights by agreements which limit the right of the collaborative party to an exclusive right only as it pertains to the field of use, as defined by the applicable project’s scope of work. In this manner, we anticipate that we will receive future benefit and use of such intellectual property outside the field of use, as defined by any given scope of work.* There can be no assurance that we will be able to obtain final approval of any patents.
*
Trademarks
*
We believe in the superiority of our technology and products.* As a result, we have invested in the development and protection of the names of our products in order to drive consumer awareness and loyalty to the brand.* To protect this investment, we have registered, and continue to seek registration, of these trademarks and continuously monitor and aggressively pursue users of names and marks that potentially infringe upon our registered trademarks.* We currently own registered trademarks to the following brand names of certain of our products:* OsteoSponge®, OsteoWrap®, OsteoLock®, BacFast®, OsteoSelect®, and Elutia® and have recently applied to register hMatrix™.* We recently sued Allosource for infringing our OsteoSponge® trademark by marketing their competitive allograft product under the name “AlloSponge.”* See “Business - Legal Proceedings.”
*
Trade Secrets
*
To safeguard our proprietary knowledge and technology, we rely heavily upon trade secret protection and non-disclosure/confidentiality agreements with employees, consultants and third party collaboration partners with access to our confidential information. There can be no assurance, however, that these measures will adequately protect against the unauthorized disclosure or use of confidential information, or that third parties will not be able to independently develop similar technology. Additionally, there can be no assurance that any agreements concerning confidentiality and non-disclosure will not be breached, or if breached, that we will have an adequate remedy to protect us against losses. Although we believe our proprietary technology has value, because of rapid technological changes in the medical industry, we also believe that proprietary protection is of less significance than factors such as the intrinsic knowledge and experience of our management, advisory board, consultants and personnel and their ability to identify unmet market needs and to create, invent, develop and market innovative and differentiated new medical devices.
Click to expand...

Bacterin is an awful company that stole Osteosponge and Allosource. Allosource bought UTah tissue bank and had the recipe from Allosource. Your r***** brothers left the company and started Bacterin with Allosources recipe. FRAUD! Allosource is non profit and didnt want to waste time on these losers and know they will fail in the end. I met the rep in Dallas. She was a clueless Aims rep.
 




Too funny just got a call from a medical center wanting Osteosponge and since I have not worked there for a long time I let them know they could get the same stuff and better service from Allosource. The jerks that let me go can't even do simple follow up on accounts. So glad ship is sinking fast.
 




Top Bottom
Back
Quote